Christian Herzog
Assistant Professor
Also affiliated: University of North Carolina at Charlotte (1998); Goethe University Frankfurt (2001–2009); University of Vienna (1995–1999); Goethe-Institute United Kingdom (2001); Mercy Medical Center (1999); Queen Saovabha Memorial Institute (1999); Medical University of Graz (2021); University of Zurich (1989); Robert Koch Institute (2016); Commissariat à l'Énergie Atomique et aux Énergies Alternatives (2003–2009); Institut für Medizinische Informatik, Biometrie und Epidemiologie (2005); Universitätsklinik für Neurologie (1988); Universitätsklinikum des Saarlandes (2002); CEA Paris-Saclay - Etablissement de Fontenay-aux-roses (2003–2009); Central Arkansas Veterans Healthcare System (2007–2025); Bioforschung Austria (1995); Orthopädische Universitätsklinik (1988); University Hospital Frankfurt (2004); National Cancer Institute (1999); Berufsgenossenschaftliche Unfallklinik Frankfurt am Main (2004); Ludwig Boltzmann Institute for Cancer Research (1995); John L. McClellan Memorial Veterans Hospital (1999); Memorial Hospital (1999); Chirurgische Universitätsklinik Heidelberg (1994); Universitätsbibliothek Johann Christian Senckenberg (2007); The Ohio State University (2003); University of Amsterdam (2000); Saarland University (1994–2000)
Faculty Researcher
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Christian Herzog's research focuses on understanding the molecular mechanisms underlying kidney diseases, particularly membranous nephropathy and acute kidney injury.
His work has identified novel autoantigens and prognostic biomarkers in these conditions. This includes investigating serine protease HTRA1 and TGFBR3-associated proteins as targets in membranous nephropathy, and SOD1 as a biomarker for acute kidney injury following cardiothoracic surgery. Herzog also studies the role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury.
His research group has also explored the immunological responses to SARS-CoV-2 infection, including the development of ACE2 autoantibodies and the induction of anti-idiotype antibodies in transgenic mouse models following vaccination. Herzog holds a h-index of 31 with 94 total publications and 2,923 total citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Joseph H. Holthoff, Yanping Izak Harville, Aaron J. Storey, and J. Craig Forrest.
Metrics
- h-index: 31
- Publications: 94
- Citations: 3,004
Selected Publications
-
Proteomic Profiling of Complement Components in Glomerular Disease (2026)
-
The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025)
-
Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice (2025)
-
FSGS in an Adult Transplant Recipient Possibly Linked to a New Antibody against WT1 (2024)
-
SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023)
-
Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry (2023)
-
Urine Mass Spectrometry Can Distinguish Prerenal and Intrarenal AKI (2022)
-
Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry (2022)
-
Development of ACE2 autoantibodies after SARS-CoV-2 infection (2021)
-
Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy (2021)
-
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy (2021)
-
NCAM1 Is an Autoantigen in Membranous Lupus Nephritis (2020)
-
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis (2020)
-
NELL1 is a target antigen in malignancy-associated membranous nephropathy (2020)
-
Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits (2019)
Grants & Funding
As listed on this researcher's institutional profile.
- Pilot: Glomerular biomarkers of progression in IgA nephropathy NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases via University of Pennsylvania Co-Investigator
- Meprin A Metalloproteinase in Acute Kidney Injury NIH Co-Investigator
- A Device for Detection of Acute Kidney Injury NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases via Nephsmart, LLC Principal Investigator
- Factors Associated with Outcomes in Patients on Continuous Dialysis Dialysis Clinic, Inc. Principal Investigator
- Development of a Precision Medicine-Based Diagnostic Tool for Membranous Nephropathy NIH/National Institutes of Health via Arkana Laboratories Principal Investigator
Collaboration Network
Top Collaborators
- Development of ACE2 autoantibodies after SARS-CoV-2 infection
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
Showing 5 of 10 shared publications
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry
- Proteomic Profiling of Complement Components in Glomerular Disease
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry
- Proteomic Profiling of Complement Components in Glomerular Disease
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry
- Proteomic Profiling of Complement Components in Glomerular Disease
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- Urine Mass Spectrometry Can Distinguish Prerenal and Intrarenal AKI
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
- Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy
Similar Researchers
Based on overlapping research topics